Neuroprotective Potential of Superparamagnetic Iron Oxide Nanoparticles Along with Exposure to Electromagnetic Field in 6-OHDA Rat Model of Parkinson's Disease.
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting mainly the dopaminergic neurons of the substantia nigra leading to various motor and non-motor deficits. We explored the neuroprotective potential of superparamagnetic iron oxide nanoparticles (IONPs) along with exposure to EMF in 6-OHDA rat model of PD. IONPs were implanted at the site of lesion and 24 h thereafter the rats were exposed to magnetic fields 2 h/day for one week. Bilateral lesions of the striatum were made with 6-OHDA. The rats in all the intervention groups improved progressively over the days and by post-surgery day 4 they were active and bright. We observed a significant beneficial effect of the IONPs implantation and MF exposure on feeding behavior, gait and postural stability. There was a significant enhancement of mitochondrial function and attenuation of lesion volume in all the intervention groups as compared to PD. The results demonstrate neuroprotective effect of iron oxide nanoparticle implantation and magnetic field exposure in an in vivo 6-OHDA rat model of PD.
AI evidence extraction
Main findings
In a 6-OHDA rat model of Parkinson's disease, implantation of superparamagnetic iron oxide nanoparticles at the lesion site followed by magnetic field exposure (2 h/day for one week) was associated with significant improvements in feeding behavior, gait, and postural stability. The intervention groups also showed enhanced mitochondrial function and reduced lesion volume compared with the PD group.
Outcomes measured
- Feeding behavior
- Gait
- Postural stability
- Mitochondrial function
- Lesion volume
- General activity/brightness (post-surgery recovery)
Limitations
- No magnetic field parameters (e.g., frequency, intensity) reported in the abstract
- Sample size not reported in the abstract
- Intervention combines nanoparticle implantation and magnetic field exposure; the independent contribution of EMF exposure is unclear from the abstract
- Duration of follow-up beyond the first post-surgery days is not specified in the abstract
View raw extracted JSON
{
"study_type": "animal",
"exposure": {
"band": null,
"source": "magnetic field exposure (with implanted superparamagnetic iron oxide nanoparticles)",
"frequency_mhz": null,
"sar_wkg": null,
"duration": "2 h/day for one week (starting 24 h after implantation)"
},
"population": "6-OHDA rat model of Parkinson's disease (bilateral striatal lesions)",
"sample_size": null,
"outcomes": [
"Feeding behavior",
"Gait",
"Postural stability",
"Mitochondrial function",
"Lesion volume",
"General activity/brightness (post-surgery recovery)"
],
"main_findings": "In a 6-OHDA rat model of Parkinson's disease, implantation of superparamagnetic iron oxide nanoparticles at the lesion site followed by magnetic field exposure (2 h/day for one week) was associated with significant improvements in feeding behavior, gait, and postural stability. The intervention groups also showed enhanced mitochondrial function and reduced lesion volume compared with the PD group.",
"effect_direction": "benefit",
"limitations": [
"No magnetic field parameters (e.g., frequency, intensity) reported in the abstract",
"Sample size not reported in the abstract",
"Intervention combines nanoparticle implantation and magnetic field exposure; the independent contribution of EMF exposure is unclear from the abstract",
"Duration of follow-up beyond the first post-surgery days is not specified in the abstract"
],
"evidence_strength": "low",
"confidence": 0.7399999999999999911182158029987476766109466552734375,
"peer_reviewed_likely": "yes",
"keywords": [
"Parkinson's disease",
"6-OHDA",
"rat model",
"superparamagnetic iron oxide nanoparticles",
"magnetic field exposure",
"EMF",
"neuroprotection",
"mitochondrial function",
"lesion volume",
"motor behavior"
],
"suggested_hubs": []
}
AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.